These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34698809)

  • 1. Work participation is reduced during the development of RA, months before clinical arthritis manifests.
    Rogier C; de Jong PHP; van der Helm-van Mil AHM; van Mulligen E
    Rheumatology (Oxford); 2022 May; 61(6):2583-2589. PubMed ID: 34698809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.
    Gwinnutt JM; Leggett S; Lunt M; Barton A; Hyrich KL; Walker-Bone K; Verstappen SMM;
    Rheumatology (Oxford); 2020 Oct; 59(10):2908-2919. PubMed ID: 32097471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatigue independently predicts different work disability dimensions in etanercept-treated rheumatoid arthritis and ankylosing spondylitis patients.
    Druce KL; Aikman L; Dilleen M; Burden A; Szczypa P; Basu N
    Arthritis Res Ther; 2018 May; 20(1):96. PubMed ID: 29843776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.
    Verstappen SM
    Best Pract Res Clin Rheumatol; 2015 Jun; 29(3):495-511. PubMed ID: 26612244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient burden and joint inflammation during development of RA from arthralgia: is it similar in ACPA-positive and ACPA-negative disease?
    Khidir SJH; Krijbolder DI; Glas HK; van Mulligen E; van der Helm-van Mil AHM
    Rheumatology (Oxford); 2024 Sep; 63(9):2336-2344. PubMed ID: 38261628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TREAT Early Arthralgia to Reverse or Limit Impending Exacerbation to Rheumatoid arthritis (TREAT EARLIER): a randomized, double-blind, placebo-controlled clinical trial protocol.
    Niemantsverdriet E; Dakkak YJ; Burgers LE; Bonte-Mineur F; Steup-Beekman GM; van der Kooij SM; Boom HD; Allaart CF; de Jong PHP; van der Helm-van Mil AHM
    Trials; 2020 Oct; 21(1):862. PubMed ID: 33076964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.
    Behrens F; Tony HP; Koehm M; Schwaneck EC; Gnann H; Greger G; Burkhardt H; Schmalzing M
    Clin Rheumatol; 2020 Sep; 39(9):2583-2592. PubMed ID: 32206973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The course of fatigue during the development of rheumatoid arthritis and its relation with inflammation: a longitudinal study.
    Khidir SJH; Wouters F; van der Helm-van Mil AHM; van Mulligen E
    Joint Bone Spine; 2022 Nov; 89(6):105432. PubMed ID: 35777555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate.
    Emery P; Smolen JS; Ganguli A; Meerwein S; Bao Y; Kupper H; Chen N; Kavanaugh A
    Rheumatology (Oxford); 2016 Aug; 55(8):1458-65. PubMed ID: 27114561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of biological agents on work participation in rheumatoid arthritis patients: a systematic review.
    ter Wee MM; Lems WF; Usan H; Gulpen A; Boonen A
    Ann Rheum Dis; 2012 Feb; 71(2):161-71. PubMed ID: 21998122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT EARLIER): a randomised, double-blind, placebo-controlled, proof-of-concept trial.
    Krijbolder DI; Verstappen M; van Dijk BT; Dakkak YJ; Burgers LE; Boer AC; Park YJ; de Witt-Luth ME; Visser K; Kok MR; Molenaar ETH; de Jong PHP; Böhringer S; Huizinga TWJ; Allaart CF; Niemantsverdriet E; van der Helm-van Mil AHM
    Lancet; 2022 Jul; 400(10348):283-294. PubMed ID: 35871815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in the symptomatic phase preceding ACPA-positive and ACPA-negative RA: a longitudinal study in arthralgia during progression to clinical arthritis.
    Burgers LE; van Steenbergen HW; Ten Brinck RM; Huizinga TW; van der Helm-van Mil AH
    Ann Rheum Dis; 2017 Oct; 76(10):1751-1754. PubMed ID: 28606964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis.
    Verstappen M; Niemantsverdriet E; Matthijssen XME; le Cessie S; van der Helm-van Mil AHM
    Arthritis Res Ther; 2020 Nov; 22(1):276. PubMed ID: 33228814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Productivity loss due to absenteeism and presenteeism by different instruments in patients with RA and subjects without RA.
    Braakman-Jansen LM; Taal E; Kuper IH; van de Laar MA
    Rheumatology (Oxford); 2012 Feb; 51(2):354-61. PubMed ID: 22179729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with absenteeism, presenteeism and activity impairment in patients in the first years of RA.
    Bansback N; Zhang W; Walsh D; Kiely P; Williams R; Guh D; Anis A; Young A
    Rheumatology (Oxford); 2012 Feb; 51(2):375-84. PubMed ID: 22179728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
    Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
    Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review.
    Batko B; Rolska-Wójcik P; Władysiuk M
    Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31426543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of etanercept on work productivity in patients with early active rheumatoid arthritis: results from the COMET study.
    Anis A; Zhang W; Emery P; Sun H; Singh A; Freundlich B; Sato R
    Rheumatology (Oxford); 2009 Oct; 48(10):1283-9. PubMed ID: 19690125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-year Predictors of Presenteeism in Workers with Rheumatoid Arthritis: Disease-related Factors and Characteristics of General Health and Work.
    Boot CRL; de Wind A; van Vilsteren M; van der Beek AJ; van Schaardenburg D; Anema JR
    J Rheumatol; 2018 Jun; 45(6):766-770. PubMed ID: 29496893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study.
    Tanaka Y; Yamazaki K; Nakajima R; Komatsu S; Igarashi A; Tango T; Takeuchi T
    Mod Rheumatol; 2018 Jan; 28(1):39-47. PubMed ID: 28704126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.